147 related articles for article (PubMed ID: 21421102)
1. A prospective study of prophylactic long-acting octreotide in high-risk patients undergoing pancreaticoduodenectomy.
Graham JA; Johnson LB; Haddad N; Al-Kawas F; Carroll J; Jha R; Wong J; Maglaris D; Mertens S; Fishbein T
Am J Surg; 2011 Apr; 201(4):481-5. PubMed ID: 21421102
[TBL] [Abstract][Full Text] [Related]
2. Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands.
Vanounou T; Pratt WB; Callery MP; Vollmer CM
J Am Coll Surg; 2007 Oct; 205(4):546-57. PubMed ID: 17903728
[TBL] [Abstract][Full Text] [Related]
3. Octreotide does not prevent postoperative pancreatic fistula or mortality following Pancreaticoduodenectomy.
Barnett SP; Hodul PJ; Creech S; Pickleman J; Arahna GV
Am Surg; 2004 Mar; 70(3):222-6; discussion 227. PubMed ID: 15055845
[TBL] [Abstract][Full Text] [Related]
4. Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery.
Droeser RA; Jeanmonod P; Schuld J; Moussavian MR; Schilling MK; Kollmar O
Dig Surg; 2012; 29(6):484-91. PubMed ID: 23392293
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: results of a prospective randomized double-blinded placebo-controlled trial.
Kollmar O; Moussavian MR; Richter S; de Roi P; Maurer CA; Schilling MK
Eur J Surg Oncol; 2008 Aug; 34(8):868-875. PubMed ID: 18299182
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of pancreatic fistula following pancreaticoduodenectomy for periampullary cancer.
Popiela T; Kedra B; Sierzega M; Gurda A
Hepatogastroenterology; 2004; 51(59):1484-8. PubMed ID: 15362783
[TBL] [Abstract][Full Text] [Related]
7. [Prospective and randomized study on the usefulness of octreotide in the prevention of complications after cephalic duodeno-pancreatectomy].
Briceño Delgado FJ; López Cillero P; Rufián Peña S; Solórzano Peck G; Miño Fugarolas G; Pera Madrazo C
Rev Esp Enferm Dig; 1998 Oct; 90(10):687-94. PubMed ID: 9824933
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of octreotide in the prevention of complications after pancreaticoduodenectomy in patients with soft pancreas and non-dilated pancreatic duct: A prospective randomized trial.
El Nakeeb A; ElGawalby A; A Ali M; Shehta A; Hamed H; El Refea M; Moneer A; Abd El Rafee A
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):59-63. PubMed ID: 29428106
[TBL] [Abstract][Full Text] [Related]
9. [Role octreotide in prevention of complications after pancreatoduodenal resections].
Shatverian GA; Ratnikova NP; Mikhaĭlov IuE; Bedzhanian AL; Sidorov AN; Fisenko EP; Skipenko OG
Khirurgiia (Mosk); 2004; (2):56-60. PubMed ID: 14997883
[No Abstract] [Full Text] [Related]
10. Pancreatic fistula after pancreatic head resection; incidence, significance and management.
Hashimoto N; Yasuda C; Ohyanagi H
Hepatogastroenterology; 2003; 50(53):1658-60. PubMed ID: 14571810
[TBL] [Abstract][Full Text] [Related]
11. Does prophylactic octreotide benefit patients undergoing elective pancreatic resection?
Yeo CJ
J Gastrointest Surg; 1999; 3(3):223-4. PubMed ID: 10809581
[No Abstract] [Full Text] [Related]
12. Randomized controlled study of the effect of octreotide on pancreatic exocrine secretion and pancreatic fistula after pancreatoduodenectomy.
You DD; Paik KY; Park IY; Yoo YK
Asian J Surg; 2019 Feb; 42(2):458-463. PubMed ID: 30262436
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic irrigation around a pancreaticojejunostomy for the treatment of a pancreatic fistula after a pancreaticoduodenectomy in patients with a risky pancreatic remnant.
Nakano H; Asakura T; Sakurai J; Koizumi S; Asano T; Watanabe T; Otsubo T
Hepatogastroenterology; 2008; 55(82-83):717-21. PubMed ID: 18613441
[TBL] [Abstract][Full Text] [Related]
14. Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy.
Ecker BL; McMillan MT; Asbun HJ; Ball CG; Bassi C; Beane JD; Behrman SW; Berger AC; Dickson EJ; Bloomston M; Callery MP; Christein JD; Dixon E; Drebin JA; Castillo CF; Fisher WE; Fong ZV; Haverick E; Hollis RH; House MG; Hughes SJ; Jamieson NB; Javed AA; Kent TS; Kowalsky SJ; Kunstman JW; Malleo G; Poruk KE; Salem RR; Schmidt CR; Soares K; Stauffer JA; Valero V; Velu LKP; Watkins AA; Wolfgang CL; Zureikat AH; Vollmer CM
Ann Surg; 2018 Apr; 267(4):608-616. PubMed ID: 28594741
[TBL] [Abstract][Full Text] [Related]
15. Toward zero pancreatic fistula after pancreaticoduodenectomy with pancreaticogastrostomy.
Rosso E; Bachellier P; Oussoultzoglou E; Scurtu R; Meyer N; Nakano H; Verasay G; Jaeck D
Am J Surg; 2006 Jun; 191(6):726-32; discussion 733-4. PubMed ID: 16720139
[TBL] [Abstract][Full Text] [Related]
16. Measures to prevent pancreatic fistula after pancreatoduodenectomy: a comprehensive review.
Lai EC; Lau SH; Lau WY
Arch Surg; 2009 Nov; 144(11):1074-80. PubMed ID: 19917946
[TBL] [Abstract][Full Text] [Related]
17. Stenting and the rate of pancreatic fistula following pancreaticoduodenectomy.
Moriya T; Clark CJ; Kirihara Y; Kendrick ML; Reid Lombardo KM; Que FG; Farnell MB
Arch Surg; 2012 Jan; 147(1):35-40. PubMed ID: 22250109
[TBL] [Abstract][Full Text] [Related]
18. [Drug therapy prevention of pancreatic fistula after pancreaticoduodenectomy].
Slim K; Le Borgne J
Ann Chir; 2003 Apr; 128(3):175-6. PubMed ID: 12821085
[No Abstract] [Full Text] [Related]
19. The efficacy of the prophylactic use of octreotide after a pancreaticoduodenectomy.
Moon HJ; Heo JS; Choi SH; Joh JW; Choi DW; Kim YI
Yonsei Med J; 2005 Dec; 46(6):788-93. PubMed ID: 16385654
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of abdominal drainage in individual risk assessment of pancreatic fistula following pancreaticoduodenectomy.
Ansorge C; Nordin JZ; Lundell L; Strömmer L; Rangelova E; Blomberg J; Del Chiaro M; Segersvärd R
Br J Surg; 2014 Jan; 101(2):100-8. PubMed ID: 24306817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
